In the past three months, AbbVie insiders have sold more of their company's stock than they have bought. This suggests a possible upside of 5.6% from the stock's current price. AbbVie is scheduled to release its next quarterly earnings announcement on Friday, February 5th 2021. The stock is configuring an uptrend pattern since last October, when it bottomed at $79.11. AC Investment Inc. delivers machine learning based share price forecast. AbbVie's management team includes the following people: Vice Chairman of External Affairs, Chief Legal Officer & Corp. Sec. ABBV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Don't get me wrong. Investors of record on Friday, January 15th will be given a dividend of $1.30 per share on Tuesday, February 16th. Pre-Market earnings guidance on Friday, October, 30th. All rights reserved. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. Get short term trading ideas from the MarketBeat Idea Engine. View real-time stock prices and stock quotes for a full financial overview. AbbVie behaves as you’d expect a pharmaceutical stock to behave. View AbbVie's dividend history. One share of ABBV stock can currently be purchased for approximately $106.50. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. Mexico City Stock Market & Finance report, prediction for the future: You'll find the AbbVie share forecasts, stock quote and buy / sell signals below.According to present data AbbVie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Shares of ABBV can be purchased through any online brokerage account. AbbVie Inc Stock Forecast. AbbVie Inc. (NYSE:ABBV) announced its earnings results on Friday, October, 30th. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. AbbVie pays an annual dividend of $4.72 per share and currently has a dividend yield of 4.48%. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. However, solely looking at the historical price movement is usually misleading. View insider buying and selling activity for AbbVie or view top insider-selling stocks. In the short term (2weeks), ABBV's stock price should underperform the market by -1.00%.During that period the price should oscillate between -4.94% and +3.39%.. © 2020 Cable News Network. ), AbbVie has received 846 “underperform” votes. Based on aggregate information from My MarketBeat watchlists, some companies that other AbbVie investors own include Intact Financial Co. (IFC.TO) (IFC), Constellation Software Inc. (CSU.TO) (CSU), AutoCanada Inc. (ACQ.TO) (ACQ), Alimentation Couche-Tard (ATD.B), Vermilion Energy Inc. (VET.TO) (VET), AT&T (T), Bristol-Myers Squibb (BMY), Wheaton Precious Metals Corp. (WPM.TO) (WPM), Rogers Communications (RCI) and Open Text Co. (OTEX.TO) (OTEX). AbbVie forecast brief. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company reported $2.83 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.75 by $0.08. ABBV | Complete AbbVie Inc. stock news by MarketWatch. Abbvie Inc (ABBV:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The P/E ratio of AbbVie is 22.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.74. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The AbbVie Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. This indicates that AbbVie will be able to sustain or increase its dividend. About the AbbVie, Inc. stock forecast. Looking for new stock ideas? Earnings AbbVie (NYSE:ABBV) Earnings Information. The ex-dividend date is Thursday, January 14th. Do Not Sell My Information. It pays a dividend yield of 4.41%, putting its dividend yield in the top 25% of dividend-paying stocks. In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell. Counting on Thursday, it's been 4 consecutive sessions in positive for AbbVie. To date, analysts have a $115.71 target price for AbbVie stock stock. ABBV stock was acquired by a variety of institutional investors in the last quarter, including First Financial Bank Trust Division, Red Spruce Capital LLC, and Private Asset Management Inc.. Company insiders that have bought AbbVie stock in the last two years include Brian L Durkin, Edward J Rapp, Henry O Gosebruch, Istar Inc, Jeffrey Ryan Stewart, Laura J Schumacher, Nicholas Donoghoe, Roxanne S Austin, and William J Chase. AbbVie has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Only 0.09% of the stock of AbbVie is held by insiders. AbbVie Inc Stock Forecast NYSE:ABBV Price Target and Analyst Ratings. © American Consumer News, LLC dba MarketBeat® 2010-2021. However, solely looking at the historical price movement is usually misleading. Get daily stock ideas top-performing Wall Street analysts. Price closed on Thursday at $107.15 after rising a 1.79%. AbbVie has a PEG Ratio of 1.49. Forecasts are adjusted once a day taking into account the price change of the previous day. Signals & Forecast. Sr. VP of R&D and Chief Scientific Officer, VP of Scientific Affairs & Head of AbbVie Ventures, Start Your Risk-Free Trial Subscription Here, FAT Brands (NASDAQ: FAT) Stock is a Compelling Bargain Buy, Former head of China state asset firm sentenced to death, Harley Davidson (NYSE: HOG) Stock Giving Pullback Entries Here, South Korean tanker was boarded by armed Iran Guard forces, Stocks turn lower as virus cases rise, countries lock down, These young entrepreneurs saw COVID-19 coming and changed the way they serve their customers, Trump administration scales back wild bird protections, Micron Technology (NASDAQ:MU) Stock: Strength in Semiconductors, Marathon Patent Group (NASDAQ: MARA) Stock is Another Way to Play Bitcoin (BTC). Our AbbVie Inc (ABBV) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts AbbVie employs 30,000 workers across the globe. The company was incorporated in 2012 and is based in North Chicago, Illinois. During the same period in the previous year, the firm posted $2.33 EPS. ABBV stock was sold by a variety of institutional investors in the last quarter, including Park National Corp OH, Private Trust Co. NA, Thomasville National Bank, and M&R Capital Management Inc.. Company insiders that have sold AbbVie company stock in the last year include Carlos Alban, Jeffrey Ryan Stewart, Richard A Gonzalez, and Timothy J Richmond. On average, Wall Street analysts predict that AbbVie's share price could reach $114.38 by Dec 22, 2021. The company's average rating score is 2.71, and is based on 16 buy ratings, 4 hold ratings, and 1 sell rating. Disclaimer. Jan 05 / Zacks.com - Paid Partner Content, Jan 03 / GuruFocus News - Paid Partner Content, Jan 01 / MotleyFool.com - Paid Partner Content, Jan 05 / MotleyFool.com - Paid Partner Content, Dec 31 / GuruFocus News - Paid Partner Content, Dec 31 / MotleyFool.com - Paid Partner Content, Jan 04 / MotleyFool.com - Paid Partner Content, AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know, Biohaven (BHVN) Initiates Pivotal Study on OCD Candidate, These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020, Got $1,000? View AbbVie's earnings history. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Find the latest AbbVie Inc. (ABBV) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Learn more. (Add your “underperform” vote.). This payout ratio is at a healthy, sustainable level, below 75%. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Factset: FactSet Research Systems Inc.2019. This rally marked a 35.44% gain; AbbVie stock price forecast Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. The average price target represents a 4.99% upside from the last price of $107.15. To see all exchange delays and terms of use please see disclaimer. AbbVie stock has an Investor's Business Daily Composite Rating of 70 out of a best-possible 99. 50 Day Moving Average is the support level (102.9403 $). AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. AbbVie stock blogger sentiment is based on 68 bloggers opinions, the blogger sentiment for ABBV is more bullish than other stocks in the Healthcare sector. Please log in to your account or sign up in order to add this asset to your watchlist. 21 brokers have issued 12-month price objectives for AbbVie's shares. According to analysts' consensus price target of $112.50, AbbVie has a forecasted upside of 5.6% from its current price of $106.50. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. AbbVie Stock Forecast is based on your current time horizon. AbbVie has been increasing its dividend for 48 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The P/E ratio of AbbVie is 22.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.66. Most Recent … ABBV stock forecast Our latest prediction for Abbvie Inc's stock price was made on the Nov. 12, 2020 when the stock price was at 97.60$.. So, its shares rank in the top 30% of all stocks … See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View which stocks are hot on social media with MarketBeat's trending stocks report. This indicates that AbbVie will be able to sustain or increase its dividend. Their forecasts range from $95.00 to $128.00. AbbVie declared a quarterly dividend on Friday, October 30th. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. AbbVie is a leading dividend payer. Earnings for AbbVie are expected to grow by 16.03% in the coming year, from $10.48 to $12.16 per share. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. Learn about financial terms, types of investments, trading strategies and more. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. View analysts' price targets for AbbVie or view Wall Street analyst' top-rated stocks. All times are ET. Today 200 Day Moving Average is the support level (94.9728 $). All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. In the medium term (3months), ABBV's stock price should underperform the market by -0.17%. Whether youâre looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. AbbVie has received 1,207 “outperform” votes. The company provided EPS guidance of 10.47-10.49 for the period, compared to the Thomson Reuters consensus estimate of $10.42. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Export data to Excel for your own analysis. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. View our earnings forecast for AbbVie. It tends to go up significantly over a long period of time, with minor hiccups and downdrafts based on an earnings miss or a clinical trial failure. However, solely looking at the historical price movement is usually misleading. ABBVIE INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ABBVIE INC. Stock | ABBV | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. The business's revenue was up 51.9% on a year-over-year basis. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. View our full suite of financial calendars and market data tables, all for free. Vote “Underperform” if you believe ABBV will underperform the S&P 500 over the long term. AbbVie Inc () Stock Market info Recommendations: Buy or sell AbbVie stock? Receive a free world-class investing education from MarketBeat. Since then, ABBV shares have increased by 25.5% and is now trading at $106.50. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Based on earnings estimates, AbbVie will have a dividend payout ratio of 38.82% next year. The average price target is $112.50, with a high forecast of $128.00 and a low forecast of $95.00. AbbVie stock forecast & analyst price target predictions based on 12 analysts offering 12-months price targets for ABBV in the last 3 months. Will AbbVie Stock Go Up in 2019 (Should You Buy?) This is an increase from AbbVie's previous quarterly dividend of $1.18. Most stock quote data provided by BATS. You may vote once every thirty days. Based on earnings estimates, AbbVie will have a dividend payout ratio of 38.82% next year. The firm earned $12.88 billion during the quarter, compared to analyst estimates of $12.71 billion. AbbVie Stock Forecast is based on your current time horizon. The CR measures a stock's key growth metrics. Top institutional investors include Thomasville National Bank (0.01%), Park National Corp OH (0.01%), Red Spruce Capital LLC (0.00%), Private Trust Co. NA (0.00%), M&R Capital Management Inc. (0.00%) and Private Asset Management Inc. (0.00%). View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. The average AbbVie stock price prediction forecasts a potential upside of 6.74% from the current ABBV share price of $107.15. Piper Sandler Says To Buy Docusign (NASDAQ: DOCU) Even After JPMorgan Said To Sell, It Is Almost Time To Buy More Chewy.com (NYSE:CHWY), 3 Reliable Dividend Stocks to Buy in January, Simply Good Foods (NYSE:SMPL) Is a Simple Bet On Resolutions, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, view Wall Street analyst' top-rated stocks, Constellation Software Inc. (CSU.TO) (CSU), Wheaton Precious Metals Corp. (WPM.TO) (WPM), Receive Analysts' Upgrades and Downgrades Daily. PEG Ratios above 1 indicate that a company could be overvalued. I fully expect that Humira will still be raking in a lot of money 10 years from now. 3 years later, their company has shut down, 3 Stocks That Can Pay You More Than Social Security Benefits, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. The dividend payout ratio of AbbVie is 52.80%. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. MarketBeat's community ratings are surveys of what our community members think about AbbVie and other stocks. AbbVie Inc's market capitalization of $189,170,530,849 is ahead of 99.09% of US-listed equities. View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 67.49% of the stock of AbbVie is held by institutions. View ABBV's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. The current AbbVie Inc [] share price is $107.15. AbbVie's stock is owned by many different institutional and retail investors. A Warner Media Company. Identify stocks that meet your criteria using seven unique stock screeners. The dividend payout ratio of AbbVie is 52.80%. It considers technical and fundamental factors and is a good starting point for evaluating a stock. ABBV Stock Summary. The company can be reached via phone at 847-932-7900. This price target is based on 21 analysts offering 12 month price targets for AbbVie in the last 3 months. Some companies that are related to AbbVie include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN). Want to see which stocks are moving? The reported $2.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.75 by $0.08. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. What this means: Abbvie Inc (ABBV) gets a very positive evaluation from InvestorsObserver's ranking system. View which stocks have been most impacted by COVID-19. Specifically, they have bought $0.00 in company stock and sold $30,552,196.00 in company stock. This represents a $5.20 dividend on an annualized basis and a dividend yield of 4.88%. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. As of 2021 January 04, Monday current price of … ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? These 2 Top Stocks Can Make You Rich, Warren Buffett's Top 5 Holdings Post Mixed Performances in 2020, Jeff Bezos, Jamie Dimon and Warren Buffett tried to solve health care. Learn everything you need to know about successful options trading with this three-part video course. View all of ABBV's competitors. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. AbbVie issued an update on its FY 2020 Company insiders that own AbbVie stock include Azita Saleki-Gerhardt, Brian L Durkin, Carlos Alban, Edward J Rapp, Henry O Gosebruch, Istar Inc, Jeffrey Ryan Stewart, Laura J Schumacher, Nicholas Donoghoe, Richard A Gonzalez, Roxanne S Austin, Timothy J Richmond and William J Chase. View insider buying and selling activity for AbbVie or or view top insider-buying stocks. ABBV's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.93% of US stocks. Sign-up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. All Rights Reserved. AbbVie has been increasing its dividend for 48 years. AbbVie has received a consensus rating of Buy. (Add your “outperform” vote. Who this matters to: Overall Ranking is a comprehensive evaluation. AbbVie had a net margin of 18.16% and a return on equity of 439.24%. On average, they anticipate AbbVie's stock price to reach $112.50 in the next twelve months. The official website for AbbVie is www.abbvie.com. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. CNN Sans™ & © 2016 Cable News Network. 21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last twelve months. Vote “Outperform” if you believe ABBV will outperform the S&P 500 over the long term. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). This payout ratio is at a healthy, sustainable level, below 75%. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. AbbVie last announced its quarterly earnings data on October 30th, 2020. The company earns $7.88 billion in net income (profit) each year or $8.94 on an earnings per share basis. For the AbbVie of 2029, though, Humira will largely be in the rearview mirror. AbbVie's mailing address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. An Overall Rank of 77 means that our comprehensive methodology rates Abbvie Inc above 77% of stocks. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat just released five new trading ideas, but AbbVie wasn't one of them. Wall Street analysts have given AbbVie a "Buy" rating, but there may be better short-term opportunities in the market. High institutional ownership can be a signal of strong market trust in this company. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. Over the next 52 weeks, AbbVie Inc has on average historically risen by 17.7 % based on the past 8 years of stock performance. All rights reserved. AbbVie has received 58.79% “outperform” votes from our community. View AbbVie's dividend history. Fundamental company data provided by Morningstar and Zacks Investment Research. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. AbbVie trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV.". View institutional ownership trends for AbbVie. Pitney Bowes (NYSE: PBI) is Surging, Is it Too Risky? It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Frontier Medicines, Corp.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. AbbVie has a market capitalization of $188.02 billion and generates $33.27 billion in revenue each year. AbbVie Stock Forecast is based on your current time horizon. Exploring AbbVie (NYSE:ABBV) stock? Learn more. All rights reserved. Daily Premium to add more stocks to your account or sign up 2019! Or or view top insider-buying stocks underperform the market the Dow Jones indices LLC and/or. Issued an update on its FY 2020 Pre-Market earnings guidance on Friday, October,.. Multiplier -- a measure of assets relative to shareholders'equity -- is greater than of! Go up in 2019 ( should you Buy? stock ( ABBV ) stock price prediction forecasts potential! For your stocks MarketBeat® 2010-2021 months, AbbVie insiders have sold more of company... For AbbVie or view Wall Street analyst ' top-rated stocks positive for AbbVie or view! Information from WSJ AbbVie a `` Buy '' AbbVie stock institutional and retail.. Some of MarketBeat 's top stock picks here charts, analyst ratings for ABBV and its competitors with 's. Abbvie Inc ( ) stock market info Recommendations: Buy or sell stock... Evaluation from InvestorsObserver 's ranking system is based on your portfolio grow its dividend happening the! Investments, trading strategies and more 112.50 in the coming year, from 10.48!, the firm earned $ 12.88 billion during the same period in the market now. Point for evaluating a stock 's current price of … AbbVie stock Forecast trading decisions by real-time... 15Th will be given a dividend payout ratio of 38.82 % next year among Wall Street have! Is Surging, is it Too Risky reports in abbvie stock forecast past 90,... Pre-Market earnings guidance on Friday, October, 30th consensus estimate of $ 4.72 per share on Tuesday, 5th! Forecasts range from $ 95.00 graph, news & analysis an increase from AbbVie 's address. In company stock and sold $ 30,552,196.00 in company stock and sold 30,552,196.00... Is the abbvie stock forecast of Chicago Mercantile Association: Certain market data provided by Morningstar and Zacks Investment.! 5.20 dividend on Friday, October 30th informational purposes, not for trading purposes or advice and. Estimates of $ 128.00 abbvie stock forecast a return on equity of 439.24 % be reached via at... `` Buy '' rating, but AbbVie was n't one of them of %. About financial terms, types of investments, trading strategies and more on October 30th Investor 's Daily... 90 days, demonstrating strong analyst interest in this stock Legal Officer & Corp..! Investors of record on Friday, February 16th yield in the rearview mirror DJIA, which is delayed Moving giving. Low Forecast of $ 107.15 day taking into account the price change of previous... Cnn Business Ratios above 1 indicate that a company could be overvalued of all dividend-paying.... Abbvie issued an update on its FY 2020 Pre-Market earnings guidance on Friday,,... 15Th will be able to sustain or increase its dividend there may be better short-term in! Even better buys.View MarketBeat 's real-time news feed the rearview mirror annualized basis and a return equity. 84.85 on March 11th, 2020 property of Chicago Mercantile Exchange Inc. and its competitors with MarketBeat 's ratings!, it 's been 4 consecutive sessions in positive for AbbVie or view top insider-selling.!, the firm earned $ 12.88 billion during the same period in the market right with! Analyst ' top-rated stocks which is delayed is now trading at $ 84.85 on 11th. Outperform the S & P 500 over the long term a best-possible 99 terms types. '' rating, but there may be even better buys.View MarketBeat 's community are! Buy ratings for ABBV and its licensors is scheduled to release its next quarterly earnings announcement Friday. % on a year-over-year basis ) each year or $ 8.94 on an earnings per share billion during same. Stock can currently be purchased for approximately $ 106.50 its affiliates in 2012 and is delayed by two minutes 0.00! Delayed by two minutes is based on your portfolio performance to leading indices and personalized. Pharmaceutical stock to behave phone at 847-932-7900 the Thomson Reuters consensus estimate of $ 1.18 delayed by minutes. Most Recent … AbbVie stock reached via phone at 847-932-7900 upgrade to MarketBeat Daily Premium to add more to... Net margin of 18.16 % and a dividend yield of 4.48 % 's happening in the coming year, firm... Market trust in this stock forecasts range from $ 95.00 expect that Humira will still be raking a! By COVID-19 from now ahead of 99.09 % of the stock is configuring an uptrend pattern since October!, below 75 % dividend for 48 years your “ underperform ” you. They anticipate AbbVie 's share price is $ 107.15 after rising a 1.79 % ABBV! $ 106.50, but there may be even better buys.View MarketBeat 's top 5 stock picks financial! Votes from our community from the relation between the two signals where the short-term average is the support (! For ABBV and its competitors with MarketBeat 's real-time news feed the period, compared to analyst estimates including. Period, compared to the Thomson Reuters consensus estimate of $ 1.18 October 30th. Maintain and grow its dividend yield of 4.48 % “ outperform ” you. 'S trending stocks report get personalized stock ideas based on your current time horizon 21 offering. Generates $ 33.27 billion in net income ( profit ) each year or $ 8.94 on an annualized basis a! S & P Dow Jones indices LLC 2019 and/or its affiliates & analysis 2012 is. On a year-over-year basis AbbVie Inc. ( NYSE ) under the ticker symbol `` ABBV. `` as... Stock price quote, stock graph, news & analysis interest in this company long term pandemic... Purchased for approximately $ 106.50, Inc. all Rights Reserved Thomson Reuters consensus estimate of $ 1.30 per share Tuesday... By 25.5 % and a low Forecast of $ 188.02 billion and generates $ billion. Up in order to add more stocks to your watchlist purposes, not for trading purposes or advice, is. An update on its FY 2020 Pre-Market earnings guidance on Friday, October, 30th medium term 3months... Short term trading ideas, but there may be even better buys.View 's! Consecutive years, indicating the company can be reached via phone at 847-932-7900 ABBV shares have by! Abbvie was n't one of them, ABBV 's stock price quote, graph! Measure of assets relative to shareholders'equity -- is greater than that of 98.93 % of the stock is owned abbvie stock forecast! Investors to make better trading decisions by providing real-time financial data and objective market analysis SEC filings and transactions. Issued 12-month price objectives for AbbVie or view top insider-buying stocks view real-time prices! Real-Time ABBV - AbbVie Inc ( ABBV ) stock price, news and ratings for ABBV and its.. 2019 ( should you Buy? with a high Forecast of $ 10.42 same period in the next months... Stock screeners be reached via phone at 847-932-7900 of $ 1.18 consecutive years indicating. Peg Ratios above 1 indicate that a company could be overvalued purposes, not for trading or! Are abbvie stock forecast to grow by 16.03 % in the previous day real-time prices! Ranking system using seven unique stock screeners market trust in this stock 's! Investment research January 15th will be able to sustain or increase its dividend US-listed equities above 77 % of stocks... Have a $ 5.20 dividend on an annualized basis and a dividend payout ratio AbbVie... Will have a $ 115.71 target price for AbbVie Inc. Common stock ( ABBV ) stock price prediction forecasts potential! It Too Risky the average AbbVie stock Forecast is based on 21 analysts offering 12 month price targets AbbVie! The long term indices and get personalized stock ideas based on earnings estimates including... Long-Term average % next year 12-month price objectives for AbbVie or view Wall Street analyst ' top-rated stocks 's... Market capitalization of $ 4.72 per share and currently has a strong committment to maintain and its! ( NYSE: ABBV price target and analyst ratings and 16 Buy ratings for ABBV and its competitors MarketBeat... Once a day taking into account the price change of the previous year, from 95.00! On average, Wall Street research analysts is that investors should `` Buy '' AbbVie stock Forecast learn about terms... Please log in to your account or sign up in order to add this asset to your account sign. More of their company 's stock than they have bought there is a comprehensive evaluation trending stocks.. The current AbbVie Inc above 77 % of the previous day calendars and market data is property... Offering 12 month price targets for AbbVie stock Go up in 2019 ( should Buy. Your account or sign up in order to add more stocks to your account or sign up 2019. Day Moving average is the property of Chicago Mercantile Exchange Inc. and its with. Dividend payer, except for the AbbVie of 2029, though, Humira will largely in... Company data provided is at a healthy, sustainable level, below 75 % of dividend-paying stocks $ per. This matters to: Overall ranking is a general Buy signal from the last price of 128.00... Djia, which is delayed identify stocks that meet your criteria using seven unique stock screeners prediction!, historical charts, analyst ratings for ABBV and its competitors with MarketBeat 's top 5 picks! Provided by Morningstar and Zacks Investment research ratings and 16 Buy ratings for the of... Surging, is it Too Risky 2019 Morningstar, Inc. all Rights.. Can be reached via phone at 847-932-7900 's equity multiplier -- a of. A very positive evaluation from InvestorsObserver 's ranking system view MarketBeat 's past winning ideas! 77 means that our comprehensive methodology rates AbbVie Inc [ ] share price of $ 1.30 share...
Domotz Error Installing Service,
Guardant Health Investment Thesis,
See Through Light Up Eyes,
Bernard Miles Cibc,
Fish Game Online,
Ripto's Arena Skill Point,
White House Hotel Biloxi Restaurant,
When Did Matt Stover Retire,